Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
0(0%)
Results Posted
43%(3 trials)
Terminated
2(10%)

Phase Distribution

Ph not_applicable
4
19%
Ph phase_2
6
29%
Ph phase_3
3
14%
Ph phase_4
5
24%
Ph phase_1
2
10%

Phase Distribution

2

Early Stage

6

Mid Stage

8

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
2(10.0%)
Phase 2Efficacy & side effects
6(30.0%)
Phase 3Large-scale testing
3(15.0%)
Phase 4Post-market surveillance
5(25.0%)
N/ANon-phased studies
4(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

21

all time

Status Distribution
Completed(7)
Terminated(3)
Other(11)

Detailed Status

unknown11
Completed7
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
0
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (10.0%)
Phase 26 (30.0%)
Phase 33 (15.0%)
Phase 45 (25.0%)
N/A4 (20.0%)

Trials by Status

unknown1152%
completed733%
terminated210%
withdrawn15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT03406897Phase 1

Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients

Completed
NCT06125782Phase 2

Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial

Completed
NCT04181593Phase 3

Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease

Completed
NCT05005806Phase 2

Fish Oil (Omega 3 ) in Sjogren's Syndrome

Completed
NCT03167307Phase 3

The Omega-3 Fatty Acid Paediatric Depression Trial

Completed
NCT02990091Phase 2

Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury

Withdrawn
NCT05529576Phase 4

Multi-factor Model Constraction for Early Warning and Diagnosis of MDD

Unknown
NCT01310270Not Applicable

The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation

Completed
NCT02605148Not Applicable

TEFA Family Prevention: Glutenfree Diet to Preserve Beta-cell Function

Unknown
NCT03634644Phase 1

Omega-3 PUFA for Treatment of Patients With Idiopathic Oligoasthenoteratospermia

Unknown
NCT04836052Phase 3

Omega-3 Oil Use in COVID-19 Patients in Qatar

Unknown
NCT04694027Phase 4

Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient

Unknown
NCT04582630

Effects of Omega-3 Fatty Acids on Muscle Wasting

Unknown
NCT04140201Phase 4

Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

Unknown
NCT04030065Phase 2

Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation

Unknown
NCT03936621Phase 2

Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers

Unknown
NCT03442348Not Applicable

Omega 3 and Fibre Intervention Study to Improve Metabolic Health

Unknown
NCT02070042Not Applicable

Oxybutynin and Omega-3 for OAB (Overactive Bladder)

Terminated
NCT02532023Phase 4

The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients

Unknown
NCT00899353Phase 2

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
21